MedPath

Comparison of the effect of remifentanil and dexmedetomidine on surgeon satisfaction from surgical field and bleeding in rhinoplasty

Phase 2
Conditions
Rhinoplasty surgery.
Encounter for cosmetic surgery
Z41.1
Registration Number
IRCT20141009019470N112
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

18-45 years old
Patients undergoing rhinoplasty surgery
time of surgery is 7-10 days before menstruation time

Exclusion Criteria

Patients with liver dysfunction
Renal dysfunction
Any known allergy or hypersensitivity to study drugs
Abuse of analgesics and any addiction to opioid,
Diabetes mellitus
Hemorrhagic disease
Using anticoagulants
Cerebrovascular disease
Heart block
Cardiovascular disease
Morbid obesity
Females whom experience nausea and vomiting in their menstrual cycle
Revision rhinoplasty surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of intraoperative bleeding. Timepoint: At the end of the surgery. Method of measurement: Observasion.;Post operative pain. Timepoint: At arrival to the recovery room and at, 45,30,15 minutes. Method of measurement: Visual analogue Scale.
Secondary Outcome Measures
NameTimeMethod
Patients’ satisfactions. Timepoint: After injection of intervention drugs in the recovery room and surgery ward. Method of measurement: Likert Scale.;Surgeon’ satisfactions. Timepoint: At the end of the surgery. Method of measurement: Likert Scale.
© Copyright 2025. All Rights Reserved by MedPath